101
Participants
Start Date
August 17, 2017
Primary Completion Date
February 18, 2020
Study Completion Date
February 18, 2020
nintedanib
Drug
pirfenidone
Drug
Tri-Service General Hospital, Taipei
Far Eastern Memorial Hospital, New Taipei City
Chang Gung Memorial Hospital(Linkou), Taoyuan District
China Medical University Hospital, Taichung
Chang-Hua Christian Hospital, Changhua
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Taichung Veterans General Hospital, Taichung
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
Lead Sponsor
Boehringer Ingelheim
INDUSTRY